Physician profile
Harold E Moore
NPI 1962518316
$403.12
in general payments reported to CMS, 2019-2025
9 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $38.98 · 2021: $17.38 · 2022: $38.66 · 2023: $60.11 · 2024: $85.22 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $105.67 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $70.62 | 2020-2023 | Pediarix, Bexsero |
| Gilead Sciences, INC. | $52.77 | 2022-2025 | |
| Lilly USA, LLC | $36.61 | 2024-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $35.59 | 2023-2025 | Ozempic, Rybelsus |
| Actelion Pharmaceuticals US, INC. | $35.29 | 2024 | Opsumit, Uptravi |
| Amgen INC. | $32.73 | 2025 | Evenity, Repatha |
| Phadia US INC. | $18.98 | 2020 | |
| Spectrum Pharmaceuticals INC. | $14.86 | 2025 | Rolvedon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.